Global Latent Tuberculosis Infection (LTBI) Testing Market, 2021-2027

February 2022 | 69 pages | ID: G97D0CAAC254EN
Gen Consulting Company

Abstracts

Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB) disease. According to Gen Consulting Company, the global latent tuberculosis infection (LTBI) testing market size is expected to increase from USD 1,344 million in 2020 to USD 1,942 million by 2027, garnering a CAGR of 5.4% over the evaluated period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global latent tuberculosis infection (LTBI) testing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The latent tuberculosis infection (LTBI) testing market is segmented on the basis of type, end user, and region. The latent tuberculosis infection (LTBI) testing market is segmented as below:

By type:

• tuberculin skin test (TST)
• interferon gamma released assay (IGRA)

By end user:

• hospitals
• diagnostic centers
• laboratories
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The market research report covers the analysis of key stake holders of the global latent tuberculosis infection (LTBI) testing market. Some of the leading players profiled in the report include Abbott Laboratories, ARKRAY, Inc., Becton, Dickinson and Company, bioMerieux S.A., Lionex Gmbh, Oxford Immunotec Global PLC, Qiagen N.V., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global latent tuberculosis infection (LTBI) testing market.
• To classify and forecast the global latent tuberculosis infection (LTBI) testing market based on type, end user, and region.
• To identify drivers and challenges for the global latent tuberculosis infection (LTBI) testing market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global latent tuberculosis infection (LTBI) testing market.
• To identify and analyze the profile of leading players operating in the global latent tuberculosis infection (LTBI) testing market.

Why Choose This Report

• Gain a reliable outlook of the global latent tuberculosis infection (LTBI) testing market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR LATENT TUBERCULOSIS INFECTION (LTBI) TESTING BY TYPE

5.1 Tuberculin skin test (TST)
  5.1.1 Market size and forecast
5.2 Interferon gamma released assay (IGRA)
  5.2.1 Market size and forecast

PART 6. GLOBAL MARKET FOR LATENT TUBERCULOSIS INFECTION (LTBI) TESTING BY END USER

6.1 Hospitals
  6.1.1 Market size and forecast
6.2 Diagnostic centers
  6.2.1 Market size and forecast
6.3 Laboratories
  6.3.1 Market size and forecast
6.4 Others
  6.4.1 Market size and forecast

PART 7. GLOBAL MARKET FOR LATENT TUBERCULOSIS INFECTION (LTBI) TESTING BY REGION

7.1 Asia Pacific
  7.1.1 Market size and forecast
7.2 Europe
  7.2.1 Market size and forecast
7.3 North America
  7.3.1 Market size and forecast
7.4 Rest of the World (RoW)
  7.4.1 Market size and forecast

PART 8. KEY COMPETITOR PROFILES

8.1 Abbott Laboratories
8.2 ARKRAY, Inc.
8.3 Becton, Dickinson and Company
8.4 bioMerieux S.A.
8.5 Lionex Gmbh
8.6 Oxford Immunotec Global PLC
8.7 Qiagen N.V.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY